Skip to main content
. 2016 Jun 24;18(12):1260–1267. doi: 10.1111/jch.12853

Table 1.

Demographic and Baseline Characteristics of ENCORE Trial Participants by eGFR Group

All (N=144) eGFR ≥90 (n=74) eGFR <90 (n=70)
Age, y 52.0 (9.6) 47.9 (7.0) 56.3 (10.2)
Female sex, No. (%) 94 (65) 56 (79) 32 (46)
Race, No. (%)
White 86 (60) 40 (54) 46 (66)
African American 56 (39) 32 (43) 24 (34)
Other 2 (1) 2 (3) 0 (0)
Years of education 15.2 (2.6) 15.3 (2.5) 15.0 (2.7)
Annual household income, No. (%)
<$25,000 21 (17) 13 (21) 8 (13)
$25,000–50,000 31 (25) 17 (27) 14 (23)
$50,000–100,000 44 (36) 21 (33) 23 (38)
≥$100,000 27 (22) 12 (19) 15 (25)
Weight, kg 94.0 (14.1) 94.2 (14.7) 93.9 (13.6)
BMI, kg/m2 33.2 (3.9) 33.9 (4.1) 32.3 (3.5)
BP, mm Hg
Clinic SBP 137.7 (8.8) 136.5 (8.1) 139.0 (9.3)
Clinic DBP 85.5 (6.4) 87.0 (5.9) 84.0 (6.5)
Ambulatory SBP 136.9 (12.1) 136.0 (12.0) 137.7 (12.4)
Ambulatory DBP 81.3 (8.3) 82.1 (7.8) 80.4 (8.8)
Serum creatinine, mg/dL 0.94 (0.17) 0.85 (0.12) 1.04 (0.16)
eGFR, mL/min/m2 89.1 (15.0) 99.9 (9.5) 77.3 (9.6)
Dietary sodium intake 3231 (1051) 3183 (986) 3280 (1119)
DASH adherence score 3.7 (1.3) 3.6 (1.3) 3.9 (1.3)
Aerobic fitness (peak VO2, mL/kg/min) 23.4 (6.2) 23.1 (5.3) 23.8 (7.0)
Treatment group
DASH+WM, No. (%) 49 26 (35) 23 (33)
DASH‐A, No. (%)0 46 22 (30) 24 (34)
UC, No. (%) 49 26 (35) 23 (33)

Abbreviations: BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; DASH, Dietary Approaches to Stop Hypertension; DASH+WM, DASH plus weight management; DASH‐A, DASH alone; eGFR, estimated glomerular filtration rate; ENCORE, the Exercise and Nutritional Interventions for Cardiovascular Health trial; SBP, systolic blood pressure; UC, usual care; VO2, peak oxygen uptake. eGFR reported in mL/min/1.73m2. Values are expressed as mean (standard deviation) unless otherwise indicated.